Recurrent neuroblastoma Trials in Arcadia, United States
Conditions / Recurrent neuroblastoma / Arcadia, United States
Recurrent neuroblastoma is a medical condition with active clinical research programs worldwide.
12 total trials for this combination
Showing top 10 of 12 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00309907 | Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant | COMPLETED | PHASE2 |
| NCT00101270 | Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas | COMPLETED | PHASE1 |
| NCT00004078 | Irinotecan in Treating Children With Refractory Solid Tumors | COMPLETED | PHASE2 |
| NCT00030667 | Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of Childhood | COMPLETED | PHASE2 |
| NCT01334515 | Biological Therapy, Sargramostim, and Isotretinoin in Treating Patients With Relapsed or Refractory Neuroblastoma | COMPLETED | PHASE2 |
| NCT00091182 | Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment | COMPLETED | PHASE2 |
| NCT00012181 | Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas | COMPLETED | PHASE1 |
| NCT00331643 | Ixabepilone in Treating Young Patients With Refractory Solid Tumors | COMPLETED | PHASE2 |
| NCT00077454 | Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors | COMPLETED | PHASE1 |
| NCT00075634 | Decitabine, Doxorubicin, and Cyclophosphamide in Treating Children With Relapsed or Refractory Solid Tumors or Neuroblastoma | COMPLETED | PHASE1 |